FDA 483 - Vetix Inc - October 16, 2019

Vet RX Inc, an own label animal drug distributor in Lexington, KY, was cited for significant quality control deficiencies during an FDA inspection from September 19 to October 16, 2019. Observations included failures to thoroughly review out-of-specification batches, a lack of a written stability testing program, and inadequate validation of manufacturing processes for their animal drug products. These issues indicate a potential risk to product quality and efficacy.